Ann: Cellmid Investor Presentation, page-27

From p 25 of the presentation.
Lyramid
Manufacturing started in Q3 and will finish end of Q4 2019. This time next year
Preclinical is due to start now and finish end of Q4 2019.
Clinical Phase starts July 1 2019

Kinera
Manufacturing supposedly finished End of Q4 2018. Like now.
Preclinical has been in progress since Jan 1st 2018 and Ends Jan 1st 2019
Clinical Phase starts Jan 1st 2019.

All the talk of Clinical phases prior to this has been that partners would be sought.
Now we are getting the phrase " developed inhouse" which I take to mean that it would be developed by CDY.

If this is correct I might suggest that there is, has been, and will be, quite a bit of Evolis going out the door in the meantime.

And then there is the teaser with a box and a question mark on 4th Quarter sales
P14